Cooper Companies, Inc. (COO) Stock Price & Analysis
Cooper Companies, Inc. (COO) rose 2.74% to USD 68.62 as of June 9, 2026 at 23:42 UTC, according to Nexqual real-time market data.
COO last closed at USD 66.79; the session ranged USD 66.2–69 on volume of 4,309,274 shares. Market capitalization is $13.38B, with a 52-week range of USD 58.89–89.83 (NMS). Source: Nexqual, June 9, 2026 at 23:42 UTC.
Key Statistics (as of June 9, 2026 at 23:42 UTC)
| Price | USD 68.62 |
|---|---|
| Change | ▲ 2.74% (up) |
| Previous Close | USD 66.79 |
| Open | USD 67.05 |
| Day Range | USD 66.2 – 69 |
| 52-Week Range | USD 58.89 – 89.83 |
| Volume | 4,309,274 shares |
| Market Cap | $13.38B |
| Exchange | NMS |
Technical Analysis (COO)
Nexqual's technical model rates COO "BUY" based on 5 bullish and 2 bearish signals across 124 daily candles, as of June 9, 2026 at 23:42 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 66.67 (neutral) |
| vs SMA50 | Above (USD 64.79) |
| MACD | 0.4 (positive) |
Analyst Ratings (COO)
Wall Street analysts rate COO "Buy" based on 14 analysts, with a mean price target of USD 80.57 (range USD 66–92), per Nexqual as of June 9, 2026 at 23:42 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 14 |
| Mean Target | USD 80.57 |
| High Target | USD 92 |
| Low Target | USD 66 |
| Buy / Hold / Sell | 10 / 5 / 1 |
Earnings (COO)
| Next Earnings Date | 2026-09-03 |
|---|---|
| EPS Estimate | USD 1.12 |
| Revenue Estimate | $1.10B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-04-30 | USD 1.21 vs est 1.09 ▲ beat |
| 2026-01-31 | USD 1.1 vs est 1.03 ▲ beat |
| 2025-10-31 | USD 1.15 vs est 1.11 ▲ beat |
| 2025-07-31 | USD 1.1 vs est 1.07 ▲ beat |
Source: Nexqual, June 9, 2026 at 23:42 UTC.
Financials & Fundamentals (COO)
| Total Revenue | $4.23B |
|---|---|
| Revenue Growth (YoY) | +7.90% |
| Gross Margin | +65.55% |
| Operating Margin | -2.87% |
| Profit Margin | +5.57% |
| ROE | +2.85% |
| Debt / Equity | 33.09 |
| Current Ratio | 1.27 |
| Total Cash | $138.80M |
| Total Debt | $2.73B |
| Free Cash Flow | $424.28M |
Source: Nexqual, June 9, 2026 at 23:42 UTC.
Financial Health Score (COO)
Nexqual rates Cooper Companies, Inc.'s overall financial health "Mixed" across five dimensions, as of June 9, 2026 at 23:42 UTC.
| Growth | Solid — Revenue +5% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 66%, operating -3% |
| Balance Sheet | Solid — $139M cash vs $2.73B debt |
| Cash Flow | Solid — FCF $424M, 10% margin |
| Efficiency | Weak — ROE 3%, ROA 2.5% |
Ownership (COO)
| Insider Ownership | +0.61% |
|---|---|
| Institutional Ownership | +107.27% |
| Shares Outstanding | 195.03M |
| Float | 193.68M |
| Short % of Float | +2.99% |
Source: Nexqual, June 9, 2026 at 23:42 UTC.
Leadership (COO)
Cooper Companies, Inc. is led by Albert G. White (age 55), President, CEO & Non-Independent Director, per Nexqual as of June 9, 2026 at 23:42 UTC.
| President, CEO & Non-Independent Director | Albert G. White (age 55) |
|---|---|
| Executive VP, CFO, Treasurer & Principal Accounting Officer | Brian G. Andrews (age 46) |
| Executive VP, COO General Counsel & Secretary | Daniel G. McBride (age 61) |
| President of CooperSurgical, Inc. | Holly R. Sheffield (age 54) |
| President of CooperVision, Inc. | Gerard H. Warner (age 60) |
Major Backers & Investors (COO)
Notable institutional backers of Cooper Companies, Inc. include T. Rowe Price, Capital Group, Browning West Lp, according to Nexqual as of June 9, 2026 at 23:42 UTC.
Active Investors
| Investor | Stake |
|---|---|
| T. Rowe Price | 8.3% |
| Capital Group | 3.8% |
| Browning West Lp | 3.58% |
| Kayne Anderson Rudnick Investment Management LLC | 3.39% |
| Price (T.Rowe) Associates Inc | 2.77% |
| NEW PERSPECTIVE FUND | 1.85% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 20.49% |
| BlackRock | 9.82% |
| State Street | 5.69% |
| Geode Capital | 2.72% |
Source: Nexqual, June 9, 2026 at 23:42 UTC.
From Cooper Companies, Inc.'s Latest SEC 10-K Filing (filed 2025-12-05)
Key Strengths & Strategy (as disclosed to the SEC)
- The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.
- The company operates in two segments, CooperVision and CooperSurgical.
- The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia.
- Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TFX | Teleflex Incorporated | USD 135.75 | ▲ 4.55% |
| MTD | Mettler-Toledo International, I | USD 1,162.79 | ▲ 0.73% |
| STE | STERIS plc (Ireland) | USD 212.88 | ▲ 0.25% |
| XRAY | DENTSPLY SIRONA Inc. | USD 10.47 | ▲ 4.7% |
| RMD | ResMed Inc. | USD 196.94 | ▲ 0.46% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:42 UTC. This page is informational and not investment advice.